Cite
HARVARD Citation
Makker, V. et al. (2022). Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer. Obstetrical & gynecological survey. 77 (5), pp. 275-276. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Makker, V. et al. (2022). Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer. Obstetrical & gynecological survey. 77 (5), pp. 275-276. [Online].